Effects of SOX10 on the proliferative, invasive, migratory, and epithelial–mesenchymal transition abilities of triple-negative breast cancer cells - Scorecard - MDSpire
Advertisement
Effects of SOX10 on the proliferative, invasive, migratory, and epithelial–mesenchymal transition abilities of triple-negative breast cancer cells
Clinical Scorecard: Impact of SOX10 on the Proliferation, Invasion, Migration, and Epithelial-Mesenchymal Transition of Triple-Negative Breast Cancer Cells
At a Glance
Category
Detail
Condition
Triple-Negative Breast Cancer (TNBC)
Key Mechanisms
SOX10 promotes proliferation, migration, and invasion through the Wnt/β-catenin signaling pathway and induces epithelial-mesenchymal transition (EMT).
Target Population
Patients with Triple-Negative Breast Cancer (TNBC).
Care Setting
Oncology research and clinical settings.
Key Highlights
SOX10 overexpression enhances TNBC cell proliferation, migration, and invasion.
SOX10 knockdown significantly inhibits these malignant behaviors.
SOX10 regulates EMT markers and Wnt/β-catenin pathway components.
Wnt pathway activation can reverse EMT suppression from SOX10 knockdown.
SOX10-Wnt/β-catenin axis is a potential therapeutic target for TNBC.
Guideline-Based Recommendations
Diagnosis
Utilize immunohistochemical labeling for SOX10 in TNBC diagnosis.
Management
Consider targeting the SOX10-Wnt/β-catenin pathway in therapeutic strategies.
Monitoring & Follow-up
Monitor SOX10 expression levels as a potential prognostic marker.
Risks
High SOX10 expression may correlate with poor prognosis and aggressive disease.
Patient & Prescribing Data
Patients diagnosed with Triple-Negative Breast Cancer (TNBC).
Current treatment primarily involves chemotherapy due to lack of targeted therapies.
Clinical Best Practices
Regular assessment of SOX10 expression in TNBC patients.
Incorporate EMT markers in the evaluation of TNBC progression.
Explore combination therapies targeting the Wnt/β-catenin pathway.
